Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
N-acetylcysteine Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Mar/06/2021 2 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021 10 0
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
Theaflavin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 2 0